Header Logo

JAMES LEE

TitleSenior Faculty
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address7200 CAMBRIDGE
ORCID ORCID Icon0000-0002-3101-7281 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Huang Z, O'Leary KJ, Nutescu EA, Jack M, Chen T, Ruhnke GW, Lee JC, George D, House LK, Knoebel R, Rasmussen LV, Hartman S, Choksi A, Yeo KJ, Perera MA, Ratain MJ, Meltzer DO, O'Donnell PH. Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clin Pharmacol Ther. 2026 Jan; 119(1):109-119. PMID: 40847467; PMCID: PMC12746525.
      Citations:    Fields:    
    2. Kido K, Lee JC, O'Neil D, Eckel SF. The layered learning practice model: Ensuring accomplishment of both practice and pharmacy education. Am J Health Syst Pharm. 2025 Jan 24; 82(3):e207-e210. PMID: 39135429.
      Citations:    
    3. Cavallari LH, Hicks JK, Patel JN, Elchynski AL, Smith DM, Bargal SA, Fleck A, Aquilante CL, Killam SR, Lemke L, Ochi T, Ramsey LB, Haidar CE, Ho T, El Rouby N, Monte AA, Allen JD, Beitelshees AL, Bishop JR, Bousman C, Campbell R, Cicali EJ, Cook KJ, Duong B, Tsermpini EE, Girdwood ST, Gregornik DB, Grimsrud KN, Lamb N, Lee JC, Lopez RO, Mazhindu TA, Morris SA, Nagy M, Nguyen J, Pasternak AL, Petry N, van Schaik RHN, Schultz A, Skaar TC, Al Alshaykh H, Stevenson JM, Stone RM, Tran NK, Tuteja S, Woodahl EL, Yuan LC, Lee CR, Lopez RO. The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation. Pharmacogenet Genomics. 2025 Jan 01; 35(1):1-11. PMID: 39485373; PMCID: PMC11664750.
      Citations:    
    4. Park JJ, Cabel GY, Cheng KK, Dang J, Ardati AK, Han J, Lee JC, Park JJ, Cabel GY, Cheng KK, Dang J, Ardati AK, Han J, Lee JC. Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention. Pharmacogenomics. 2024; 25(7):293-298. PMID: 38884958; PMCID: PMC11404693.
      Citations:    
    5. Cheng KK, San Andres C, Salam E, Han J, Lee JC. Rates of 30-Day and 90-Day Readmission Between Genotype-Optimal and Genotype-Suboptimal Antiplatelet Therapy Prescribing After Percutaneous Coronary Intervention. Am J Cardiol. 2023 09 01; 202:218-222. PMID: 37473671.
      Citations:    
    6. Kim K, Duarte JD, Galanter WL, Han J, Lee JC, Cavallari LH, Nutescu EA. Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations. Pharmacogenomics. 2023 04; 24(6):303-314. PMID: 37166395.
      Citations:    
    7. Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, Lawson JW, Patel B, Krishnan JA, Shapiro NL, Martin DE, Kindzelski AL, Leifer ES, Joo J, Lyu L, Pennella A, Everett BM, Geraci MW, Anstrom KJ, Ortel TL, ACTIV-4C Study Group. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Ann Intern Med. 2023 04; 176(4):515-523. PMID: 36940444; PMCID: PMC10064277.
      Citations:    
    8. Cavallari LH, Limdi NA, Beitelshees AL, Lee JC, Duarte JD, Franchi F, Tuteja S, Giri J, Empey PE, Kreutz RP, Skaar TC, Allen JM, Coons JC, Gong Y, McDonough CW, Stevenson JM, Thomas CD, Johnson JA, Stouffer GA, Angiolillo DJ, Lee CR, IGNITE Network. Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2023 03; 113(3):615-623. PMID: 36306392; PMCID: PMC9957848.
      Citations:    
    9. Kido K, Slain D, Kamal KM, Lee JC. Adapting the layered learning model to a virtual international exchange program. Curr Pharm Teach Learn. 2022 12; 14(12):1500-1505. PMID: 36402695.
      Citations:    
    10. Socco S, Wake DT, Lee JC, Dunnenberger HM, Socco S, Wake DT, Lee JC, Dunnenberger HM. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review. Pharmacogenomics. 2022 11; 23(17):933-948. PMID: 36326000.
      Citations:    
    11. Beitelshees AL, Thomas CD, Empey PE, Stouffer GA, Angiolillo DJ, Franchi F, Tuteja S, Limdi NA, Lee JC, Duarte JD, Kreutz RP, Skaar TC, Coons JC, Giri J, McDonough CW, Rowland R, Stevenson JM, Thai T, Vesely MR, Wellen JT, Johnson JA, Winterstein AG, Cavallari LH, Lee CR, Implementing Genomics in Practice (IGNITE) Network Pharmacogenetics Working Group. CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. J Am Heart Assoc. 2022 02 15; 11(4):e024159. PMID: 35156424; PMCID: PMC9245803.
      Citations:    
    12. Zolekar A, Kim K, Lee JC, Han J, Duarte JD, Galanter WL, Cavallari LH, Nutescu EA, Zolekar A, Kim K, Lee JC, Han J, Duarte JD, Galanter WL, Cavallari LH, Nutescu EA. Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing. Pharmacogenomics. 2022 01; 23(2):85-95. PMID: 35001645.
      Citations:    
    13. Saulsberry L, Danahey K, Middlestadt M, O'Leary KJ, Nutescu EA, Chen T, Lee JC, Ruhnke GW, George D, House L, van Wijk XMR, Yeo KJ, Choksi A, Hartman SW, Knoebel RW, Friedman PN, Rasmussen LV, Ratain MJ, Perera MA, Meltzer DO, O'Donnell PH. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10; 11(12). PMID: 34945816; PMCID: PMC8709436.
      Citations:    
    14. Duarte JD, Dalton R, Elchynski AL, Smith DM, Cicali EJ, Lee JC, Duong BQ, Petry NJ, Aquilante CL, Beitelshees AL, Empey PE, Johnson JA, Obeng AO, Pasternak AL, Pratt VM, Ramsey LB, Tuteja S, Van Driest SL, Wiisanen K, Hicks JK, Cavallari LH, IGNITE Network Pharmacogenetics Working Group. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing. Genet Med. 2021 12; 23(12):2335-2341. PMID: 34282303; PMCID: PMC8633054.
      Citations:    
    15. Lee JC, Lin PH, Haaf CM. Opportunities for recruiting international graduates of doctor of pharmacy programs for residency training: An academic health center perspective. Am J Health Syst Pharm. 2021 06 07; 78(12):1137-1144. PMID: 33787844.
      Citations:    
    16. Kido K, Ghaffar YA, Lee JC, Bianco C, Shimizu M, Shiga T, Hashiguchi M. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS One. 2021; 16(6):e0252549. PMID: 34086768; PMCID: PMC8177531.
      Citations:    
    17. Rahman S, Srisuwananukorn A, Molokie RE, Gowhari M, Njoku F, Hussain FA, Lee J, Nutescu EA, Gordeuk VR, Saraf SL, Han J. Evaluation of point-of-care International Normalized Ratio in sickle cell disease. Res Pract Thromb Haemost. 2021 May; 5(4):e12533. PMID: 34095734; PMCID: PMC8159702.
      Citations:    
    18. Quinn AL, Bhat S, Lee JC, Quinn AL, Bhat S, Lee JC. Effect of CYP2C9 *11/*11 genotype on initial and long-term warfarin dose requirement and therapeutic response. Pharmacogenomics. 2020 12; 21(18):1271-1277. PMID: 33350885.
      Citations:    
    19. Lee CR, Thomas CD, Beitelshees AL, Tuteja S, Empey PE, Lee JC, Limdi NA, Duarte JD, Skaar TC, Chen Y, Cook KJ, Coons JC, Dillon C, Franchi F, Giri J, Gong Y, Kreutz RP, McDonough CW, Stevenson JM, Weck KE, Angiolillo DJ, Johnson JA, Stouffer GA, Cavallari LH, IGNITE Network Pharmacogenetics Working Group. Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. Clin Pharmacol Ther. 2021 03; 109(3):705-715. PMID: 32897581; PMCID: PMC7902344.
      Citations:    
    20. Flowers SA, Bhat S, Lee JC. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability. Pharmacotherapy. 2020 07; 40(7):704-712. PMID: 32463481.
      Citations:    
    21. Kido K, Lee JC, Hellwig T, Gulseth MP. Use of Direct Oral Anticoagulants in Morbidly Obese Patients. Pharmacotherapy. 2020 01; 40(1):72-83. PMID: 31834939.
      Citations:    
    22. Hicks JK, Aquilante CL, Dunnenberger HM, Gammal RS, Funk RS, Aitken SL, Bright DR, Coons JC, Dotson KM, Elder CT, Groff LT, Lee JC. Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice. J Am Coll Clin Pharm. 2019 Jun; 2(3):303-313. PMID: 32984775; PMCID: PMC7516785.
      Citations:    
    23. Cavallari LH, Van Driest SL, Prows CA, Bishop JR, Limdi NA, Pratt VM, Ramsey LB, Smith DM, Tuteja S, Duong BQ, Hicks JK, Lee JC, Obeng AO, Beitelshees AL, Bell GC, Blake K, Crona DJ, Dressler L, Gregg RA, Hines LJ, Scott SA, Shelton RC, Weitzel KW, Johnson JA, Peterson JF, Empey PE, Skaar TC, IGNITE Network. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing. Genet Med. 2019 10; 21(10):2255-2263. PMID: 30894703; PMCID: PMC6754805.
      Citations:    
    24. Manzoor BS, Cheng WH, Lee JC, Uppuluri EM, Nutescu EA. Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review. Ann Pharmacother. 2017 Dec; 51(12):1122-1137. PMID: 28735551.
      Citations:    
    25. Quinn AL, Liko I, Lee JC. Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement. Pharmacogenomics. 2017 Jul; 18(11):1051-1057. PMID: 28685643.
      Citations:    
    26. Lee JC, Horner KE, Krummel ML, McDanel DL. Clinical and Financial Outcomes Evaluation of Multimodal Pharmacist Warfarin Management of a Statewide Urban and Rural Population. J Pharm Pract. 2018 Apr; 31(2):150-156. PMID: 28441899.
      Citations:    
    27. Hellenbart E, Drambarean B, Lee J, Nutescu EA. The evolving role of dabigatran etexilate in clinical practice. Expert Opin Pharmacother. 2015; 16(13):2053-72. PMID: 26245513.
      Citations:    
    28. Lin SW, Kang WY, Lin DT, Lee J, Wu FL, Chen CL, Tseng YJ. Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system. BMC Med Genomics. 2014; 7 Suppl 1:S13. PMID: 25079609; PMCID: PMC4101312.
      Citations:    
    LEE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (104)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _